Merck & Co., Inc. (MRK) Insider Transactions
Explore official ownership filings, with every record linked to its source.
MRK · Merck & Co., Inc.
How to read this data ↗View six-calendar-month insider history →
Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-11-01Filed 2026-11-03 | DIAZ PAUL JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 The price reported is the closing price of Merck Common Stock on the business day immediately prior to the effective date of the Director's service. References: F1, F3, F2 | A Award / grantPhantom Stock · Derivative | 613.073A | 149.52 | Direct | Form 4 ↗0000310158-26-000245 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.